zmynd11 links histone h33k36me3 transcription elongation tumour suppression 
recognition modified histones reader proteins plays critical role regulation chromatin1 h3k36 trimethylation h3k36me3 deposited onto nucleosomes transcribed regions rna polymerase ii elongation yeast mark turn recruits epigenetic regulators reset chromatin relatively repressive state thus suppressing cryptic transcription2 however much less known role h3k36me3 transcription regulation mammals complicated transcription-coupled incorporation histone variant h33 gene bodies3 show candidate tumour suppressor zmynd11 specifically recognizes h3k36me3 h33 h33k36me3 regulates rna polymerase ii elongation structural studies show addition trimethyl-lysine binding aromatic cage within pwwp domain h33-dependent recognition mediated encapsulation h33-specific ser residue composite pocket formed tandem bromo-pwwp domains zmynd11 chromatin immunoprecipitation followed sequencing shows genome-wide co-localization zmynd11 h3k36me3 h33 gene bodies occupancy requires pre-deposition h33k36me3 although zmynd11 associated highly expressed genes functions unconventional transcription corepressor modulating rna polymerase ii elongation stage zmynd11 critical repression transcriptional program essential tumour cell growth; low expression levels zmynd11 breast cancer patients correlate worse prognosis consistently overexpression zmynd11 suppresses cancer cell growth vitro tumour formation mice together study identifies zmynd11 h33-specific reader h3k36me3 links histone-variant-mediated transcription elongation control tumour suppression 
